Market Access Advisory
Where Market Access Meets Momentum
Access isn’t a box to check. It’s the backbone of your brand’s success. At RxAccess, we partner with visionary biopharma teams to design bold, data-driven strategies that drive real results, from Phase II to post-exclusivity. Our Access Advisory offering delivers the insight, clarity, and confidence you need to launch strong, scale fast, and sustain value in an evolving payer landscape.
If you’re looking to unlock access, de-risk decisions, and get ahead of what payers will demand, you’re in the right place.
Strategy That Goes Beyond the Deck
We don’t just advise. We activate.
Our cross-functional strategists work side by side with clinical, HEOR, pricing, and commercial teams to build market access plans that are both grounded and go-to-market ready. No fluff. No guesswork. Just strategic guidance that delivers.
What We Deliver
Clinical Development
Build with the end in mind
- Align trial design with payer expectations
- Assess access viability and payer mix early
- Map the evidence strategy to future coverage decisions
Pre-Launch & Launch
Make launch readiness a reality
- Create access roadmaps and critical timelines
- Conduct gap assessments and payer segmentation
- Shape pricing strategy and contracting plans
- Pressure-test positioning with advisory boards
Uptake & Growth
Stay ahead of the curve
- Track coverage shifts and pull-through dynamics
- Monitor competitor access and market moves
- Refresh value messaging based on outcomes and feedback
Maturity & LoE
Plan for what’s next, not just what’s now
- Develop LoE and renewal playbooks
- Design biosimilar mitigation strategies
- Sustain pricing through value-focused contracting
Why Teams Choose RxAccess
Built-in payer intelligence
- Lifecycle-aligned strategy from Day 1
- Cross-functional by design
- Real-world execution, not just theory